These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis. Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299 [TBL] [Abstract][Full Text] [Related]
4. Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing. Guay DR; Awni WM; Halstenson CE; Kenny MT; Keane WF; Matzke GR Antimicrob Agents Chemother; 1989 Nov; 33(11):2012-5. PubMed ID: 2532874 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment. Bonati M; Traina GL; Rosina R; Buniva G J Antimicrob Chemother; 1988 Jan; 21 Suppl A():29-37. PubMed ID: 2965129 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis. Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G; Bonati M Eur J Clin Pharmacol; 1986; 31(4):501-4. PubMed ID: 2949981 [TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Bowley JA; Pickering SJ; Scantlebury AJ; Ackrill P; Jones DM J Antimicrob Chemother; 1988 Jan; 21 Suppl A():133-9. PubMed ID: 2965125 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers. Smithers JA; Kulmala HK; Thompson GA; Antony KK; Lewis EW; Ruberg SJ; Kenny MT; Dulworth JK; Brackman MA Antimicrob Agents Chemother; 1992 Jan; 36(1):115-20. PubMed ID: 1534211 [TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of teicoplanin. Rowland M Clin Pharmacokinet; 1990 Mar; 18(3):184-209. PubMed ID: 2138946 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis. Dahl NV; Foote EF; Searson KM; Fein JL; Kapoian T; Steward CA; Sherman RA Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intraperitoneal cefazolin and ceftazidime coadministered to CAPD patients. Elwell RJ; Manley HJ; Frye RF; Bailie GR Int J Artif Organs; 2005 Aug; 28(8):808-16. PubMed ID: 16211531 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteers. Thompson GA; Smithers JA; Kenny MT; Dulworth JK; Kulmala HK; Yuh L; Lewis EW; Antony KK Biopharm Drug Dispos; 1992 Apr; 13(3):213-20. PubMed ID: 1533542 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and bioavailability of a new formulation of teicoplanin following intravenous and intramuscular administration to humans. Antony KK; Lewis EW; Kenny MT; Dulworth JK; Brackman MB; Kuzma R; Yuh L; Eller MG; Thompson GA J Pharm Sci; 1991 Jun; 80(6):605-7. PubMed ID: 1834827 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study. Chang MJ; Namgung H; Choi HD; Song YR; Kim SG; Oh JM; Shin WG Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):504-9. PubMed ID: 22151828 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis. Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]